Amphipathic and hydrophobic regions of plasma and cellular proteins

The target 'Amphipathic and hydrophobic regions of plasma and cellular proteins' refers to structural motifs that are typically sequestered within the interior of proteins or lipid bilayers but become exposed during injury, denaturation, or disease (Moloughney & Weisleder, 2012). These exposed hydrophobic patches can lead to pathological protein aggregation, increased blood viscosity, and the adhesion of damaged blood cells to the vascular endothelium (Adams-Graves et al., 1997). This target is primarily associated with the therapeutic use of non-ionic surfactants, most notably Poloxamer 188 (DrugBank DB06751). By binding to these exposed regions, such agents help stabilize cell membranes, restore normal rheological properties of blood, and prevent the progression of tissue damage in conditions like sickle cell disease and ischemia-reperfusion injury (Orringer et al., 2001). While not a single molecular entity or gene product, these regions represent a critical biophysical target for maintaining cellular and vascular integrity under physiological stress.

Other names

Hydrophobic protein domainsAmphipathic protein domainsExposed hydrophobic patchesDamaged cell membrane regions

The drug acts as a non-ionic surfactant that binds to exposed hydrophobic regions of proteins and damaged cell membranes, thereby reducing blood viscosity, preventing pathological cell-cell adhesion, and promoting membrane repair (Orringer et al., 2001; Moloughney & Weisleder, 2012).